Evidence map›Paper›PMID 42763645›Full record

ArticleIranian journal of pharmaceutical research : IJPR

ALDH1A3 Inhibition by

Nilufar Torabi, Gholamreza Taheripak, Nabaa Najjar, Mohammad Amin Nooraniyan Esfehani, Najme Sadat Hoseini, Ghahraman Abedi-Firouzjaei

Abstract read
In one paragraph

Article in Iranian journal of pharmaceutical research : IJPR. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Nilufar TorabiDepartment of Biochemistry, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.ORCID https://orcid.org/0000-0001-8898-3256
Gholamreza TaheripakDepartment of Biochemistry, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Nabaa NajjarDepartment of Biochemistry, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Mohammad Amin Nooraniyan EsfehaniDepartment of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Najme Sadat HoseiniDepartment of Biochemistry, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Ghahraman Abedi-FirouzjaeiDepartment of Biochemistry, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.ORCID https://orcid.org/0000-0001-8898-3256

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Diabetes mellitus is a chronic condition caused by insufficient insulin secretion or impaired insulin action. Traditionally, pancreatic β-cell loss has been attributed to hyperglycemia-induced apoptosis. However, more recent evidence indicates that β-cells can also undergo dedifferentiation, a process in which they lose their specialized identity and revert to a precursor-like state. ALDH1A3 has been reported as a marker associated with dedifferentiated β-cells in diabetes, making it a potential molecular target for studies of β-cell identity and their redifferentiation. Objectives: This study aimed to evaluate the potential interactions between phytochemicals in Methods: This in silico study evaluated phytochemicals reported in the root extract of Results: Docking analysis suggested that several Conclusions: Among the evaluated

Indexed as

ALDH1A3 InhibitionComputational PharmacologyDiabetes MellitusMolecular DockingMolecular DynamicsPhytochemicalsProsopis farcta

Identifiers

PMID42763645
PMCPMC13589463

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.